No Difference in Intra-Arterial and Intramuscular Delivery of Autologous Bone Marrow Cells in Patients with Advanced Critical Limb Ischemia

No Difference in Intra-Arterial and Intramuscular Delivery of Autologous Bone Marrow Cells in Patients with Advanced Critical Limb Ischemia

Stem cell therapy has been proposed to be an alternative therapy in patients with critical limb ischemia (CLI), not eligible for endovascular or surgical revascularization. We compared the therapeutic effects of intramuscular (IM) and intra-arterial (IA) delivery of bone marrow cells (BMCs) and inve...

Full description

Bibliographic Details
Main Authors: Andrej Klepanec, Martin Mistrik, Cestmir Altaner, Martina Valachovicova, Ingrid Olejarova, Roman Slysko, Tibor Balazs, Terezia Urlandova, Daniela Hladikova, Branislav Liska, Jan Tomka, Ivan Vulev, Juraj Madaric M.D., Ph.D.
Format: Article
Language:English
Published: SAGE Publishing 2012-09-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368912X636948

Internet

https://doi.org/10.3727/096368912X636948

Similar Items